WindMIL Therapeutics Presents New Marrow-Infiltrating Lymphocytes (MILs®)
09 Nov 2020 //
GLOBENEWSWIRE
WindMIL Therapeutics Opens Combination Therapy Portion of its Ph2a Trial
21 Apr 2020 //
GLOBENEWSWIRE
09 Nov 2020 //
GLOBENEWSWIRE
21 Apr 2020 //
GLOBENEWSWIRE